REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,466,343 | +41.8% | 89,102 | +37.1% | 0.01% | +60.0% |
| Q2 2023 | $1,738,937 | +24.9% | 65,007 | +1.2% | 0.01% | +25.0% |
| Q1 2023 | $1,392,002 | -5.1% | 64,266 | +4.4% | 0.00% | -20.0% |
| Q4 2022 | $1,466,240 | +21.7% | 61,555 | +0.8% | 0.01% | +25.0% |
| Q3 2022 | $1,205,000 | +22.5% | 61,091 | +21.1% | 0.00% | +33.3% |
| Q2 2022 | $984,000 | -49.8% | 50,465 | -34.3% | 0.00% | -25.0% |
| Q1 2022 | $1,959,000 | +1.3% | 76,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,933,000 | -8.5% | 76,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $2,113,000 | -13.3% | 76,800 | 0.0% | 0.00% | -20.0% |
| Q2 2021 | $2,438,000 | -7.6% | 76,800 | +33.6% | 0.01% | -16.7% |
| Q1 2021 | $2,638,000 | +22.7% | 57,500 | +5.9% | 0.01% | +20.0% |
| Q4 2020 | $2,150,000 | +164.1% | 54,300 | +132.1% | 0.01% | +150.0% |
| Q3 2020 | $814,000 | +10.1% | 23,400 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $739,000 | +54.6% | 23,400 | +7.3% | 0.00% | 0.0% |
| Q1 2020 | $478,000 | – | 21,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |